| Name | 4-[(2-methylpropan-2-yl)oxycarbonylamino]-1H-pyrazole-5-carboxylic acid |
|---|---|
| Synonyms | 4-tert-butoxycarbonylamino-1H-pyrazole-3-carboxylic acid |
| Molecular Formula | C9H13N3O4 |
|---|---|
| Molecular Weight | 227.21700 |
| Exact Mass | 227.09100 |
| PSA | 107.80000 |
| LogP | 1.46850 |
| HS Code | 2933199090 |
|---|
|
~85%
896466-71-0 |
| Literature: ASTEX THERAPEUTICS LIMITED Patent: WO2007/77435 A1, 2007 ; Location in patent: Page/Page column 238; 244 ; WO 2007/077435 A1 |
|
~83%
896466-71-0 |
| Literature: ASTEX THERAPEUTICS LIMITED Patent: WO2008/1101 A2, 2008 ; Location in patent: Page/Page column 292; 298-299 ; |
|
~%
896466-71-0 |
| Literature: ASTEX THERAPEUTICS LIMITED Patent: US2010/55094 A1, 2010 ; |
| HS Code | 2933199090 |
|---|---|
| Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |